Nurix Therapeutics, Inc. Quarterly Revenues in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Nurix Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q1 2019 to Q1 2024.
  • Nurix Therapeutics, Inc. Revenues for the quarter ending February 29, 2024 was $16.6M, a 30.7% increase year-over-year.
  • Nurix Therapeutics, Inc. Revenues for the twelve months ending February 29, 2024 was $80.9M, a 94% increase year-over-year.
  • Nurix Therapeutics, Inc. annual Revenues for 2023 was $77M, a 99.3% increase from 2022.
  • Nurix Therapeutics, Inc. annual Revenues for 2022 was $38.6M, a 29.8% increase from 2021.
  • Nurix Therapeutics, Inc. annual Revenues for 2021 was $29.8M, a 66.9% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $80.9M $16.6M +$3.9M +30.7% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $77M $15.2M +$8.38M +123% Sep 1, 2023 Nov 30, 2023 10-K 2024-02-15
Q3 2023 $68.6M $18.5M +$7.68M +71.1% Jun 1, 2023 Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $60.9M $30.7M +$19.2M +168% Mar 1, 2023 May 31, 2023 10-Q 2023-07-13
Q1 2023 $41.7M $12.7M +$3.06M +31.8% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-10
Q4 2022 $38.6M $6.78M -$613K -8.29% Sep 1, 2022 Nov 30, 2022 10-K 2024-02-15
Q3 2022 $39.2M $10.8M +$539K +5.26% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-12
Q2 2022 $38.7M $11.4M +$4.34M +61.2% Mar 1, 2022 May 31, 2022 10-Q 2023-07-13
Q1 2022 $34.4M $9.62M +$4.61M +92% Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-13
Q4 2021 $29.8M $7.4M +$707K +10.6% Sep 1, 2021 Nov 30, 2021 10-K 2023-02-09
Q3 2021 $29M $10.3M +$6.17M +151% Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-06
Q2 2021 $22.9M $7.09M +$2.91M +69.6% Mar 1, 2021 May 31, 2021 10-Q 2022-07-07
Q1 2021 $20M $5.01M +$2.15M +75% Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-08
Q4 2020 $17.8M $6.69M +$4.83M +259% Sep 1, 2020 Nov 30, 2020 10-K 2021-02-16
Q3 2020 $13M $4.09M -$6.5M -61.4% Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-14
Q2 2020 $19.5M $4.18M -$5.26M -55.7% Mar 1, 2020 May 31, 2020 10-Q 2021-07-13
Q1 2020 $24.7M $2.86M -$6.37M -69% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-13
Q4 2019 $31.1M $1.86M Sep 1, 2019 Nov 30, 2019 10-K 2021-02-16
Q3 2019 $10.6M Jun 1, 2019 Aug 31, 2019 10-K 2021-02-16
Q2 2019 $9.44M Mar 1, 2019 May 31, 2019 10-K 2021-02-16
Q1 2019 $9.23M Dec 1, 2018 Feb 28, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.